iRhythm Technologies, Inc.
San Francisco, CA · Founded 2006 · CIK 0001388658 · Medtech · Public
Wearable ECG monitors that capture heartbeat data for cardiac arrhythmia detection
irhythmtech.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $59M
- 6 Form D · May 2014
- 148 months since last filing
- Contracts
- $163K
- 1 award · Veterans Affairs
- #476 of 4531 in medtech
- Patents
- 40
- 20 granted · 20 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2008201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $6,536,306 | |
| Private capital raised | Form D · SEC | $10,000,002 | |
| Private capital raised | Form D · SEC | $6,669,999 | |
| Private capital raised | Form D · SEC | $3,498,860 | |
| Private capital raised | Form D · SEC | $15,108,928 | |
| Federal contract | Department of Veterans Affairs · Zio Patch | $162,500 | |
| Private capital raised | Form D · SEC | $17,343,275 |
Federal contract · USAspendingForm D · SECPress
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 473 | CMP Scientific Corp | $167K | $300K |
| 474 | IONICSCALE LLC | $166K | — |
| 475 | GPB Scientific, Inc. | $164K | $41M |
| 476 | iRhythm Technologies, Inc. | $163K | $59M |
| 477 | Coalesenz Inc. | $163K | — |
| 478 | ProNova Solutions, LLC | $161K | $40M |
| 479 | Glaukos Corporation | $160K | $76M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Press
iRhythm Technologies Q2 Earnings Call HighlightsMarketBeat
Founders & Team
- Tiba AynechiDirector
- Sam BraschDirector
- Casper de ClercqDirector
- Matthew GarrettExecutive Officer
- Michael GoldbergDirector
- Chris GrantDirector
- Joshua GreenDirector
- Shelly GuyerExecutive Officer
- Steve JohnsonExecutive Officer
- Roberta KatzDirector
- Kevin KingDirector · Executive Officer
- Uday KumarDirector · Executive Officer
- Vijay LathiDirector
- Judith LenaneExecutive Officer
- Hardwin MeadDirector
- R. MeadDirector
- R. Hardwin MeadDirector
- Raymond ScottDirector
- William StarlingDirector
- William WillisDirector · Executive Officer
Patents
- Cardiac Arrhythmia Detectiongranted
- Physiological Signal Detection And Correlationapplication
- Multi-Sensor Differential Measurement for Blood Pressure Determinationapplication
- Time Alignment of Physiological Signals from Multiple Devicesapplication
- Scanning Techniques to Determine Sensor Placementapplication
- Optical Sensor Integration into Chest Patchapplication
- Physiological Measurement Initiation Using Multiple Sensorsapplication
- Wearable Optical Physiological Monitoring Device Adhesionapplication
- Wearable Monitorgranted
- Multiparameter Cuffless Blood Pressure Monitoring Systemapplication
- Activity Level and Fall Detection Using Accelerometer Dataapplication
- Physiological Monitoring Using Low Sample Rate Accelerometer Dataapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.